Condition
Invasive Fungal Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Invasive Fungal Disease clinical trials that are recruiting, at sites in 3 countries (most in China (3), France (1), Germany (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Invasive Fungal Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Tracking invasive fungal infections after allogeneic hematopoietic stem cell transplant | — | Beijing, Beijing Municipality | Recruiting | May 6, 2026 |
| Treating breakthrough invasive fungal infections in blood cancer patients with liposomal amphotericin B versus isavuconazole/posaconazole | — | Tianjin, Tianjin Municipality | Recruiting | Aug 22, 2025 |
| Evaluating the effectiveness of amphotericin B and azoles for invasive fungal infections | — | Chengdu, Sichuan | Recruiting | Feb 11, 2025 |
| Immune monitoring during invasive mold infections. | — | Paris | Recruiting | Feb 29, 2024 |
| Global registry for emerging invasive fungal infections | — | Cologne, North Rhine-Westphalia | Recruiting | Nov 21, 2012 |
All recruiting trials (5)
-
Tracking invasive fungal infections after allogeneic hematopoietic stem cell transplant
We will follow people who had an allogeneic stem cell transplant to see how often serious fungal infections occur and which clinical factors predict them.
-
Treating breakthrough invasive fungal infections in blood cancer patients with liposomal amphotericin B versus isavuconazole/posaconazole
This project will test whether liposomal amphotericin B or isavuconazole/posaconazole works better and is safer for adults with blood cancers who develop breakthrough invasive fungal infections after antifungal prophylaxis.
-
Evaluating the effectiveness of amphotericin B and azoles for invasive fungal infections
This study looks at how well amphotericin B and azole antifungals work and how safe they are for patients with invasive fungal infections based on their medical records.
-
Immune monitoring during invasive mold infections.
This project will test whether tracking T-cell immune checkpoints can identify adults with invasive mold infections who might benefit from adding immunotherapy to antifungal treatment.
-
Global registry for emerging invasive fungal infections
This study is collecting information about invasive fungal infections to better understand how they spread, how they are diagnosed, and how well different treatments work for people affected by them.
Related topics
Quick answers
How many Invasive Fungal Disease clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.